MERCK

MRK

$245.88B

Mega Cap

NASDAQHealthcare🇺🇸North America73.0K employees

Drugs in Pipeline

196

Phase 3 Programs

119

Upcoming Catalysts

Next Catalyst

Jan 12, 2026

24d

Drug Pipeline

Drug Name	Phase	Indication	Designations
Zanzalintinib	Phase 3	Renal Cell Carcinoma	-
DOR/ISL	Phase 3	HIV Infection	-
Rocuronium bromide (Org 9426)	Phase 3	Muscle Relaxation	-
Rocuronium 0.6 mg/kg intubating dose	Phase 3	Anesthesia	-
Rocuronium bolus maintenance	Phase 3	Anesthesia	-
V114	Phase 3	Pneumococcal Infections	-
sitagliptin phosphate	Phase 3	Type 2 Diabetes	-
Infliximab	Phase 3	Psoriasis	-
Ertugliflozin 15 mg	Phase 3	Type 2 Diabetes Mellitus	-
Metformin IR	Phase 3	Type 2 Diabetes Mellitus	-
Zoster Vaccine Live	Phase 3	Herpes Zoster	-
ER niacin/laropiprant	Phase 3	Diabetes Mellitus Type 2	-
Grazoprevir + Elbasvir	Phase 3	Hepatitis C Infection	-
Cetuximab + concomitant boost radiotherapy	Phase 3	Squamous Cell Carcinoma of the Head and Neck	-
brentuximab vedotin	Phase 3	Hodgkin Lymphoma	-
Placebo	Phase 3	Chronic Cough	-
L50/H12.5/A5	Phase 3	Hypertension	-
MK0826, /Duration of Treatment : 8 Weeks	Phase 3	Complicated Intra-Abdominal Infections	-
bortezomib	Phase 3	Multiple Myeloma	-
sugammadex	Phase 3	Neuromuscular Blockade	-
Tedizolid Phophate	Phase 3	Skin Diseases, Infectious	-
MK0507A, dorzolamide hydrochloride (+) timolol maleate	Phase 3	Glaucoma	-
MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 24 weeks	Phase 3	Osteoporosis	-
raltegravir potassium	Phase 3	HIV Infections	-
rotavirus vaccine, live, oral, pentavalent	Phase 3	Rotavirus Infections	-
Grazoprevir/Elbasvir	Phase 3	Hepatitis C	-
Temozolomide	Phase 3	Glioblastoma	-
Cisplatin	Phase 3	Gastric Neoplasms	-
Placebo to sitagliptin	Phase 3	Type 2 Diabetes Mellitus	-
laropiprant/niacin (MK0524A)	Phase 3	Hypercholesterolemia	-
Sitagliptin	Phase 3	Type 2 Diabetes Mellitus	-
9vHPV vaccine	Phase 3	Papillomavirus Infections	-
Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live	Phase 3	Measles	-
Gonal-f®	Phase 3	Assisted Reproductive Techniques	-
Ibrutinib	Phase 3	Chronic Lymphocytic Leukemia	-
COL-1620	Phase 3	Luteal Hormone Supplementation in In-vitro Fertilization	-
V441, diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant), & Haemophilus influenza type b conjugate vaccine	Phase 3	Diphtheria	-
V501	Phase 3	Human	-
Comparator: sitagliptin 100 mg	Phase 3	Diabetes Mellitus, Type 2	-
losartan potassium (+) hydrochlorothiazide	Phase 3	Hypertension	-
Opevesostat	Phase 3	Prostate Cancer Metastatic	-
Sotatercept	Phase 3	Pulmonary Arterial Hypertension	-
Bezlotoxumab	Phase 3	Clostridium Difficile Infection	-
PCV20	Phase 3	Pneumococcal Infection	-
Ertugliflozin	Phase 3	Type 2 Diabetes Mellitus	-
Peginterferon alfa-2b	Phase 3	Carcinoma, Hepatocellular	-
Ipragliflozin	Phase 3	Type 2 Diabetes Mellitus	-
Rocuronium bromide	Phase 3	Anesthesia	-
Pemetrexed	Phase 3	Carcinoma, Nonsquamous Non-small-cell Lung	-
IMI/REL	Phase 3	Suspected or Documented Gram-negative Bacterial Infection	-
MK0966, rofecoxib	Phase 3	Postoperative Pain	-
Posaconazole oral suspension	Phase 3	Mycoses	-
Follitropin alfa liquid formulation	Phase 3	Infertility	-
Micronised Progesterone	Phase 3	Infertility	-
Imipenem+Cilastatin/Relebactam	Phase 3	Complicated Intra-abdominal Infection	-
zoster vaccine live (ZOSTAVAX™)	Phase 3	Herpes Zoster	-
Doravirine	Phase 3	HIV-1	-
Telcagepant	Phase 3	Migraine	-
Lenvatinib	Phase 3	Non-small Cell Lung Cancer	-
V503 (9-valent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] vaccine)	Phase 3	Human Papillomavirus Infection	-
V116	Phase 3	Pneumococcal Infection	-
Omarigliptin	Phase 3	Type 2 Diabetes Mellitus	-
MR Prednisone	Phase 3	Rheumatoid Arthritis	-
Pembrolizumab 200 mg	Phase 3	Non-Small-Cell Lung Carcinoma	-
Placebo to omarigliptin	Phase 3	Type 2 Diabetes Mellitus	-
Enfortumab vedotin (EV)	Phase 3	Bladder Cancer	-
Cetuximab	Phase 3	Gastric Cancer	-
Combination of (a) pegylated interferon alfa-2b and (b) rebetol	Phase 3	Liver Transplantation	-
Gefapixant 45 mg twice daily (BID)	Phase 3	Chronic Cough	-
Gefapixant	Phase 3	Chronic Cough	-
Indinavir sulfate	Phase 3	HIV Infections	-
V503	Phase 3	Papillomavirus Infections	-
Pembrolizumab/Vibostolimab Co-Formulation	Phase 3	Small Cell Lung Carcinoma	-
Saizen®	Phase 3	Fibromyalgia	-
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live	Phase 3	Measles	-
Enlicitide Decanoate	Phase 3	Hypercholesterolemia	-
V419	Phase 3	Bacterial Infections	-
Suvorexant	Phase 3	Insomnia	-
methotrexate	Phase 3	Psoriasis	-
5-FU	Phase 3	Metastatic Esophageal Squamous Cell Carcinoma	-
Vorinostat	Phase 3	Mesothelioma	-
Oxaliplatin	Phase 3	Colorectal Neoplasms	-
rolofylline	Phase 3	Heart Failure, Congestive	-
Comparator: Quadrivalent Human Papillomavirus (HPV) vaccine	Phase 3	Neoplasms, Glandular and Epithelial	-
Gardasil	Phase 3	Papillomavirus Infections	-
Cetrorelix acetate	Phase 3	Polycystic Ovarian Syndrome	-
Bevacizumab	Phase 3	Ovarian Cancer	-
MK0966 / Duration of Treatment: 1 Days	Phase 3	Pain, Postoperative Arthroscopy	-
Pembrolizumab/Vibostolimab	Phase 3	Lung Neoplasms	-
caspofungin acetate	Phase 3	Fungal Infection	-
Pembrolizumab (+) Berahyaluronidase alfa	Phase 3	Lung Cancer	-
Paclitaxel	Phase 3	Metastatic Non-Small Cell Lung Cancer	-
MK-6072	Phase 3	Clostridium Difficile Infection	-
Supportive care measures	Phase 3	Non-small Cell Lung Cancer (NSCLC)	-
ZOSTAVAX™ (concomitant)	Phase 3	Herpes Zoster	-
Doxorubicin	Phase 3	Breast Neoplasms	-
Comparator: RECOMBIVAX HB™ Hepatitis B Vaccine (Recombinant)	Phase 3	Hepatitis B	-
MK0974 50 mg	Phase 3	Migraine	-
Vitamin D3	Phase 3	Osteoporosis	-
neostigmine and glycopyrrolate or atropine	Phase 3	Neuromuscular Blockade	-
Glipizide	Phase 3	Diabetes Mellitus, Type 2	-
Dexamethasone	Phase 3	Metastatic Castration-resistant Prostate Cancer (mCRPC)	-
M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX®	Phase 3	Measles	-
regorafenib	Phase 3	Colorectal Cancer	-
sitagliptin phosphate (+) metformin hydrochloride	Phase 3	Type 2 Diabetes Mellitus	-
V110, pneumococcal vaccine polyvalent	Phase 3	Healthy	-
Reformulated Raltegravir	Phase 3	HIV Infection	-
Background PAH Therapy	Phase 3	Pulmonary Arterial Hypertension	-
BIC/FTC/TAF	Phase 3	HIV-1 Infection	-
MK0991, caspofungin acetate / Duration of Treatment:	Phase 3	Fungal Infection	-
daptomycin	Phase 3	Pneumonia, Bacterial	-
Ertugliflozin 5 mg	Phase 3	Type 2 Diabetes Mellitus	-
Carboplatin	Phase 3	Carcinoma, Squamous Cell, Non-small-cell Lung	-
alvimopan	Phase 3	Ileus	-
pembrolizumab	Phase 3	Non-small Cell Lung Cancer	-
Nemtabrutinib	Phase 3	Chronic Lymphocytic Leukemia	-
Prevnar 13™	Phase 3	Pneumococcal Infections	-
Zoster Vaccine, Live (Zostavax™)	Phase 3	Shingles	-
Comparator: placebo	Phase 3	Type 2 Diabetes Mellitus	-
denufosol tetrasodium (INS37217)	Phase 2	Cystic Fibrosis	-
OPT-80	Phase 2	Diarrhea	-
Ridaforolimus	Phase 2	Sarcoma	-
Sacituzumab tirumotecan	Phase 2	Colorectal Cancer	-
Boceprevir (BOC)	Phase 2	Chronic Hepatitis C	-
Avelumab	Phase 2	Squamous Non-Small Cell Lung Cancer	-
Dalotuzumab	Phase 2	Carcinoma, Non-small-cell Lung	-
MK-8777	Phase 2	Depression	-
MK0249	Phase 2	Attention-Deficit/Hyperactivity Disorder (ADHD)	-
Patritumab Deruxtecan	Phase 2	Malignant Neoplasm	-
ARQ 197	Phase 2	Pancreatic Neoplasms	-
Farnesyl Protein Transferase Inhibitor	Phase 2	Leukemia	-
Quavonlimab	Phase 2	Advanced Solid Tumors	-
Grazoprevir	Phase 2	Chronic Hepatitis C (CHC)	-
ARQ 501	Phase 2	Cancer	-
MK-4830	Phase 2	Carcinoma, Non-Small-Cell Lung	-
MK0431, sitagliptin phosphate / Duration of Treatment: 21 Weeks	Phase 2	Diabetes Mellitus, Type II	-
Prevnar 13®	Phase 2	Streptococcus Pneumoniae Infection	-
M5717 330 mg	Phase 2	Acute Malaria	-
Aprepitant	Phase 2	Post-operative Nausea	-
Pembrolizumab/Quavonlimab	Phase 2	Colorectal Cancer	-
MK-8435 (Org 25935) 4-8 mg	Phase 2	Schizophrenia	-
Comparator: RECOMBIVAX HB™	Phase 2	Hepatitis B	-
MK-1167	Phase 2	Alzheimer Disease	-
Bomedemstat	Phase 2	Thrombocythemia, Essential	-
Posaconazole	Phase 2	Mycoses	-
INS37217 Nasal Spray	Phase 2	Perennial Allergic Rhinitis	-
Preladenant	Phase 2	Parkinson Disease	-
MK0777	Phase 2	Generalized Anxiety Disorder	-
Naproxen	Phase 2	Endometriosis-related Pain	-
Uprifosbuvir	Phase 2	Hepatitis C	-
SCH 530348	Phase 2	Arterial Obstructive Diseases	-
MK-6096	Phase 2	Migraine	-
Pneumococcal Conjugate Vaccine (V114)	Phase 2	Pneumococcal Infections	-
MK0557	Phase 2	Obesity	-
Coformulation favezelimab/pembrolizumab	Phase 2	Esophageal Squamous Cell Carcinoma (ESCC)	-
Pembrolizumab/vibostolimab coformulation	Phase 2	Bladder Cancer	-
V114 Aluminum-adjuvanted	Phase 2	Pneumococcal Infections	-
Vibostolimab/Pembrolizumab	Phase 2	Carcinoma, Renal Cell	-
Zilovertamab vedotin	Phase 2	B-cell Acute Lymphoblastic Leukemia	-
MK-3120	Phase 2	Urothelial Carcinoma	-
MK0431, sitagliptin phosphate / Duration of Treatment: 12 Weeks	Phase 2	Type 2 Diabetes Mellitus	-
Navarixin	Phase 2	Solid Tumors	-
Daptomycin for Injection	Phase 2	Bacteremia	-
Rescue medication	Phase 2	Non-Muscle Invasive Bladder Cancer	-
Placebo (for gefapixant)	Phase 2	Refractory Chronic Cough	-
UFOX + Cetuximab	Phase 2	Previously Untreated Metastatic Colorectal Cancer	-
Ribavirin	Phase 2	Hepatitis C	-
irinotecan hydrochloride	Phase 2	Metastatic Colorectal Cancer	-
Ritonavir	Phase 2	HIV Infections	-
Epinastine Nasal Spray	Phase 2	Seasonal Allergic Rhinitis	-
Comparator: niacin / Duration of Treatment: 17 Weeks	Phase 2	Flushing	-
Sofosbuvir	Phase 2	Hepatitis C	-
MK-0941	Phase 2	Type 2 Diabetes Mellitus	-
Raludotatug Deruxtecan (R-DXd)	Phase 2	Gastrointestinal Cancer	-
diquafosol tetrasodium (INS365) ophthalmic solution	Phase 2	Dry Eye Disease	-
Tepotinib	Phase 2	Non-small Cell Lung Cancer	-
Elbasvir	Phase 2	Hepatitis C	-
MK-3795	Phase 2	VHL Gene Mutation	-
Efprezimod alfa	Phase 2	Graft Versus Host Disease	-
boceprevir (SCH 503034)	Phase 2	Chronic Hepatitis C	-
MK2295	Phase 2	Pain, Postoperative	-
Clesrovimab	Phase 2	Respiratory Syncytial Viruses	-
Ramucirumab	Phase 2	Gastroesophageal Junction	-
V114 Lot 1	Phase 2	Pneumococcal Infections	-
Vaniprevir 600 mg b.i.d.	Phase 2	Hepatitis C, Chronic	-
Belzutifan	Phase 2	Renal Cell Carcinoma	-
zoster vaccine live (Oka/Merck)	Phase 2	Shingles	-
favezelimab/pembrolizumab	Phase 2	Hodgkin Lymphoma	-
Gefapixant 45 mg	Phase 2	Chronic Cough	-
luspatercept	Phase 2	B-Thalassemia	-
Tulisokibart	Phase 2	Hidradenitis Suppurativa	-
Raludotatug Deruxtecan	Phase 2	Ovarian Cancer Recurrent	-
Comparator: Placebo (unspecified)	Phase 2	Paranoid Schizophrenia	-
Odanacatib	Phase 2	Osteoporosis Postmenopausal	-
adavosertib	Phase 2	Ovarian Cancer	-
IDX719	Phase 2	Hepatitis C, Chronic	-

Catalyst Timeline

14 upcoming, 0 past

⭐Phase 3Next

brentuximab vedotin Phase 3 Results Expected

Jan 12, 2026brentuximab vedotin

Primary completion for brentuximab vedotin trial (NCT02684292) in Hodgkin Lymphoma

Source

⭐Phase 3

pembrolizumab Phase 3 Results Expected

Jan 12, 2026pembrolizumab

Primary completion for pembrolizumab trial (NCT02684292) in Hodgkin Lymphoma

Source

Phase 2

Belzutifan Phase 2 Results Expected

May 31, 2026Belzutifan

Primary completion for Belzutifan trial (NCT04626479) in Carcinoma, Renal Cell

Source

Phase 2

Pembrolizumab/Quavonlimab Phase 2 Results Expected

May 31, 2026Pembrolizumab/Quavonlimab

Primary completion for Pembrolizumab/Quavonlimab trial (NCT04626479) in Carcinoma, Renal Cell

Source

Phase 2

Pembrolizumab Phase 2 Results Expected

May 31, 2026pembrolizumab

Primary completion for Pembrolizumab trial (NCT04626479) in Carcinoma, Renal Cell

Source

Phase 2

Vibostolimab/Pembrolizumab Phase 2 Results Expected

May 31, 2026Vibostolimab/Pembrolizumab

Primary completion for Vibostolimab/Pembrolizumab trial (NCT04626479) in Carcinoma, Renal Cell

Source

Phase 2

Favezelimab/Pembrolizumab Phase 2 Results Expected

May 31, 2026favezelimab/pembrolizumab

Primary completion for Favezelimab/Pembrolizumab trial (NCT04626479) in Carcinoma, Renal Cell

Source

Phase 2

Lenvatinib Phase 2 Results Expected

May 31, 2026Lenvatinib

Primary completion for Lenvatinib trial (NCT04626479) in Carcinoma, Renal Cell

Source

⭐Phase 3

Pembrolizumab (+) Berahyaluronidase alfa Phase 3 Results Expected

Jun 22, 2026Pembrolizumab (+) Berahyaluronidase alfa

Primary completion for Pembrolizumab (+) Berahyaluronidase alfa trial (NCT06698042) in Lung Cancer

Source

Phase 2

Sacituzumab tirumotecan Phase 2 Results Expected

Jun 30, 2026Sacituzumab tirumotecan

Primary completion for Sacituzumab tirumotecan trial (NCT06637423) in Non-Muscle Invasive Bladder Cancer

Source

Phase 2

Rescue medication Phase 2 Results Expected

Jun 30, 2026Rescue medication

Primary completion for Rescue medication trial (NCT06637423) in Non-Muscle Invasive Bladder Cancer

Source

Phase 2

Raludotatug Deruxtecan (R-DXd) Phase 2 Results Expected

Jul 6, 2026Raludotatug Deruxtecan (R-DXd)

Primary completion for Raludotatug Deruxtecan (R-DXd) trial (NCT06864169) in Gastrointestinal Cancer

Source

Phase 2

Nemtabrutinib Phase 2 Results Expected

Sep 18, 2026Nemtabrutinib

Primary completion for Nemtabrutinib trial (NCT03162536) in Lymphoma, B-Cell

Source

Phase 2

Tulisokibart Phase 2 Results Expected

Nov 16, 2026Tulisokibart

Primary completion for Tulisokibart trial (NCT06956235) in Hidradenitis Suppurativa

Source

Regulatory Approvals

MRK News

MERCK

MRK

$245.88B

Mega Cap

NASDAQHealthcare🇺🇸North America73.0K employees

Drugs in Pipeline

196

Phase 3 Programs

119

Upcoming Catalysts

Next Catalyst

Jan 12, 2026

24d

Drug Pipeline

Drug Name	Phase	Indication	Designations
Zanzalintinib	Phase 3	Renal Cell Carcinoma	-
DOR/ISL	Phase 3	HIV Infection	-
Rocuronium bromide (Org 9426)	Phase 3	Muscle Relaxation	-
Rocuronium 0.6 mg/kg intubating dose	Phase 3	Anesthesia	-
Rocuronium bolus maintenance	Phase 3	Anesthesia	-
V114	Phase 3	Pneumococcal Infections	-
sitagliptin phosphate	Phase 3	Type 2 Diabetes	-
Infliximab	Phase 3	Psoriasis	-
Ertugliflozin 15 mg	Phase 3	Type 2 Diabetes Mellitus	-
Metformin IR	Phase 3	Type 2 Diabetes Mellitus	-
Zoster Vaccine Live	Phase 3	Herpes Zoster	-
ER niacin/laropiprant	Phase 3	Diabetes Mellitus Type 2	-
Grazoprevir + Elbasvir	Phase 3	Hepatitis C Infection	-
Cetuximab + concomitant boost radiotherapy	Phase 3	Squamous Cell Carcinoma of the Head and Neck	-
brentuximab vedotin	Phase 3	Hodgkin Lymphoma	-
Placebo	Phase 3	Chronic Cough	-
L50/H12.5/A5	Phase 3	Hypertension	-
MK0826, /Duration of Treatment : 8 Weeks	Phase 3	Complicated Intra-Abdominal Infections	-
bortezomib	Phase 3	Multiple Myeloma	-
sugammadex	Phase 3	Neuromuscular Blockade	-
Tedizolid Phophate	Phase 3	Skin Diseases, Infectious	-
MK0507A, dorzolamide hydrochloride (+) timolol maleate	Phase 3	Glaucoma	-
MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 24 weeks	Phase 3	Osteoporosis	-
raltegravir potassium	Phase 3	HIV Infections	-
rotavirus vaccine, live, oral, pentavalent	Phase 3	Rotavirus Infections	-
Grazoprevir/Elbasvir	Phase 3	Hepatitis C	-
Temozolomide	Phase 3	Glioblastoma	-
Cisplatin	Phase 3	Gastric Neoplasms	-
Placebo to sitagliptin	Phase 3	Type 2 Diabetes Mellitus	-
laropiprant/niacin (MK0524A)	Phase 3	Hypercholesterolemia	-
Sitagliptin	Phase 3	Type 2 Diabetes Mellitus	-
9vHPV vaccine	Phase 3	Papillomavirus Infections	-
Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live	Phase 3	Measles	-
Gonal-f®	Phase 3	Assisted Reproductive Techniques	-
Ibrutinib	Phase 3	Chronic Lymphocytic Leukemia	-
COL-1620	Phase 3	Luteal Hormone Supplementation in In-vitro Fertilization	-
V441, diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant), & Haemophilus influenza type b conjugate vaccine	Phase 3	Diphtheria	-
V501	Phase 3	Human	-
Comparator: sitagliptin 100 mg	Phase 3	Diabetes Mellitus, Type 2	-
losartan potassium (+) hydrochlorothiazide	Phase 3	Hypertension	-
Opevesostat	Phase 3	Prostate Cancer Metastatic	-
Sotatercept	Phase 3	Pulmonary Arterial Hypertension	-
Bezlotoxumab	Phase 3	Clostridium Difficile Infection	-
PCV20	Phase 3	Pneumococcal Infection	-
Ertugliflozin	Phase 3	Type 2 Diabetes Mellitus	-
Peginterferon alfa-2b	Phase 3	Carcinoma, Hepatocellular	-
Ipragliflozin	Phase 3	Type 2 Diabetes Mellitus	-
Rocuronium bromide	Phase 3	Anesthesia	-
Pemetrexed	Phase 3	Carcinoma, Nonsquamous Non-small-cell Lung	-
IMI/REL	Phase 3	Suspected or Documented Gram-negative Bacterial Infection	-
MK0966, rofecoxib	Phase 3	Postoperative Pain	-
Posaconazole oral suspension	Phase 3	Mycoses	-
Follitropin alfa liquid formulation	Phase 3	Infertility	-
Micronised Progesterone	Phase 3	Infertility	-
Imipenem+Cilastatin/Relebactam	Phase 3	Complicated Intra-abdominal Infection	-
zoster vaccine live (ZOSTAVAX™)	Phase 3	Herpes Zoster	-
Doravirine	Phase 3	HIV-1	-
Telcagepant	Phase 3	Migraine	-
Lenvatinib	Phase 3	Non-small Cell Lung Cancer	-
V503 (9-valent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] vaccine)	Phase 3	Human Papillomavirus Infection	-
V116	Phase 3	Pneumococcal Infection	-
Omarigliptin	Phase 3	Type 2 Diabetes Mellitus	-
MR Prednisone	Phase 3	Rheumatoid Arthritis	-
Pembrolizumab 200 mg	Phase 3	Non-Small-Cell Lung Carcinoma	-
Placebo to omarigliptin	Phase 3	Type 2 Diabetes Mellitus	-
Enfortumab vedotin (EV)	Phase 3	Bladder Cancer	-
Cetuximab	Phase 3	Gastric Cancer	-
Combination of (a) pegylated interferon alfa-2b and (b) rebetol	Phase 3	Liver Transplantation	-
Gefapixant 45 mg twice daily (BID)	Phase 3	Chronic Cough	-
Gefapixant	Phase 3	Chronic Cough	-
Indinavir sulfate	Phase 3	HIV Infections	-
V503	Phase 3	Papillomavirus Infections	-
Pembrolizumab/Vibostolimab Co-Formulation	Phase 3	Small Cell Lung Carcinoma	-
Saizen®	Phase 3	Fibromyalgia	-
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live	Phase 3	Measles	-
Enlicitide Decanoate	Phase 3	Hypercholesterolemia	-
V419	Phase 3	Bacterial Infections	-
Suvorexant	Phase 3	Insomnia	-
methotrexate	Phase 3	Psoriasis	-
5-FU	Phase 3	Metastatic Esophageal Squamous Cell Carcinoma	-
Vorinostat	Phase 3	Mesothelioma	-
Oxaliplatin	Phase 3	Colorectal Neoplasms	-
rolofylline	Phase 3	Heart Failure, Congestive	-
Comparator: Quadrivalent Human Papillomavirus (HPV) vaccine	Phase 3	Neoplasms, Glandular and Epithelial	-
Gardasil	Phase 3	Papillomavirus Infections	-
Cetrorelix acetate	Phase 3	Polycystic Ovarian Syndrome	-
Bevacizumab	Phase 3	Ovarian Cancer	-
MK0966 / Duration of Treatment: 1 Days	Phase 3	Pain, Postoperative Arthroscopy	-
Pembrolizumab/Vibostolimab	Phase 3	Lung Neoplasms	-
caspofungin acetate	Phase 3	Fungal Infection	-
Pembrolizumab (+) Berahyaluronidase alfa	Phase 3	Lung Cancer	-
Paclitaxel	Phase 3	Metastatic Non-Small Cell Lung Cancer	-
MK-6072	Phase 3	Clostridium Difficile Infection	-
Supportive care measures	Phase 3	Non-small Cell Lung Cancer (NSCLC)	-
ZOSTAVAX™ (concomitant)	Phase 3	Herpes Zoster	-
Doxorubicin	Phase 3	Breast Neoplasms	-
Comparator: RECOMBIVAX HB™ Hepatitis B Vaccine (Recombinant)	Phase 3	Hepatitis B	-
MK0974 50 mg	Phase 3	Migraine	-
Vitamin D3	Phase 3	Osteoporosis	-
neostigmine and glycopyrrolate or atropine	Phase 3	Neuromuscular Blockade	-
Glipizide	Phase 3	Diabetes Mellitus, Type 2	-
Dexamethasone	Phase 3	Metastatic Castration-resistant Prostate Cancer (mCRPC)	-
M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX®	Phase 3	Measles	-
regorafenib	Phase 3	Colorectal Cancer	-
sitagliptin phosphate (+) metformin hydrochloride	Phase 3	Type 2 Diabetes Mellitus	-
V110, pneumococcal vaccine polyvalent	Phase 3	Healthy	-
Reformulated Raltegravir	Phase 3	HIV Infection	-
Background PAH Therapy	Phase 3	Pulmonary Arterial Hypertension	-
BIC/FTC/TAF	Phase 3	HIV-1 Infection	-
MK0991, caspofungin acetate / Duration of Treatment:	Phase 3	Fungal Infection	-
daptomycin	Phase 3	Pneumonia, Bacterial	-
Ertugliflozin 5 mg	Phase 3	Type 2 Diabetes Mellitus	-
Carboplatin	Phase 3	Carcinoma, Squamous Cell, Non-small-cell Lung	-
alvimopan	Phase 3	Ileus	-
pembrolizumab	Phase 3	Non-small Cell Lung Cancer	-
Nemtabrutinib	Phase 3	Chronic Lymphocytic Leukemia	-
Prevnar 13™	Phase 3	Pneumococcal Infections	-
Zoster Vaccine, Live (Zostavax™)	Phase 3	Shingles	-
Comparator: placebo	Phase 3	Type 2 Diabetes Mellitus	-
denufosol tetrasodium (INS37217)	Phase 2	Cystic Fibrosis	-
OPT-80	Phase 2	Diarrhea	-
Ridaforolimus	Phase 2	Sarcoma	-
Sacituzumab tirumotecan	Phase 2	Colorectal Cancer	-
Boceprevir (BOC)	Phase 2	Chronic Hepatitis C	-
Avelumab	Phase 2	Squamous Non-Small Cell Lung Cancer	-
Dalotuzumab	Phase 2	Carcinoma, Non-small-cell Lung	-
MK-8777	Phase 2	Depression	-
MK0249	Phase 2	Attention-Deficit/Hyperactivity Disorder (ADHD)	-
Patritumab Deruxtecan	Phase 2	Malignant Neoplasm	-
ARQ 197	Phase 2	Pancreatic Neoplasms	-
Farnesyl Protein Transferase Inhibitor	Phase 2	Leukemia	-
Quavonlimab	Phase 2	Advanced Solid Tumors	-
Grazoprevir	Phase 2	Chronic Hepatitis C (CHC)	-
ARQ 501	Phase 2	Cancer	-
MK-4830	Phase 2	Carcinoma, Non-Small-Cell Lung	-
MK0431, sitagliptin phosphate / Duration of Treatment: 21 Weeks	Phase 2	Diabetes Mellitus, Type II	-
Prevnar 13®	Phase 2	Streptococcus Pneumoniae Infection	-
M5717 330 mg	Phase 2	Acute Malaria	-
Aprepitant	Phase 2	Post-operative Nausea	-
Pembrolizumab/Quavonlimab	Phase 2	Colorectal Cancer	-
MK-8435 (Org 25935) 4-8 mg	Phase 2	Schizophrenia	-
Comparator: RECOMBIVAX HB™	Phase 2	Hepatitis B	-
MK-1167	Phase 2	Alzheimer Disease	-
Bomedemstat	Phase 2	Thrombocythemia, Essential	-
Posaconazole	Phase 2	Mycoses	-
INS37217 Nasal Spray	Phase 2	Perennial Allergic Rhinitis	-
Preladenant	Phase 2	Parkinson Disease	-
MK0777	Phase 2	Generalized Anxiety Disorder	-
Naproxen	Phase 2	Endometriosis-related Pain	-
Uprifosbuvir	Phase 2	Hepatitis C	-
SCH 530348	Phase 2	Arterial Obstructive Diseases	-
MK-6096	Phase 2	Migraine	-
Pneumococcal Conjugate Vaccine (V114)	Phase 2	Pneumococcal Infections	-
MK0557	Phase 2	Obesity	-
Coformulation favezelimab/pembrolizumab	Phase 2	Esophageal Squamous Cell Carcinoma (ESCC)	-
Pembrolizumab/vibostolimab coformulation	Phase 2	Bladder Cancer	-
V114 Aluminum-adjuvanted	Phase 2	Pneumococcal Infections	-
Vibostolimab/Pembrolizumab	Phase 2	Carcinoma, Renal Cell	-
Zilovertamab vedotin	Phase 2	B-cell Acute Lymphoblastic Leukemia	-
MK-3120	Phase 2	Urothelial Carcinoma	-
MK0431, sitagliptin phosphate / Duration of Treatment: 12 Weeks	Phase 2	Type 2 Diabetes Mellitus	-
Navarixin	Phase 2	Solid Tumors	-
Daptomycin for Injection	Phase 2	Bacteremia	-
Rescue medication	Phase 2	Non-Muscle Invasive Bladder Cancer	-
Placebo (for gefapixant)	Phase 2	Refractory Chronic Cough	-
UFOX + Cetuximab	Phase 2	Previously Untreated Metastatic Colorectal Cancer	-
Ribavirin	Phase 2	Hepatitis C	-
irinotecan hydrochloride	Phase 2	Metastatic Colorectal Cancer	-
Ritonavir	Phase 2	HIV Infections	-
Epinastine Nasal Spray	Phase 2	Seasonal Allergic Rhinitis	-
Comparator: niacin / Duration of Treatment: 17 Weeks	Phase 2	Flushing	-
Sofosbuvir	Phase 2	Hepatitis C	-
MK-0941	Phase 2	Type 2 Diabetes Mellitus	-
Raludotatug Deruxtecan (R-DXd)	Phase 2	Gastrointestinal Cancer	-
diquafosol tetrasodium (INS365) ophthalmic solution	Phase 2	Dry Eye Disease	-
Tepotinib	Phase 2	Non-small Cell Lung Cancer	-
Elbasvir	Phase 2	Hepatitis C	-
MK-3795	Phase 2	VHL Gene Mutation	-
Efprezimod alfa	Phase 2	Graft Versus Host Disease	-
boceprevir (SCH 503034)	Phase 2	Chronic Hepatitis C	-
MK2295	Phase 2	Pain, Postoperative	-
Clesrovimab	Phase 2	Respiratory Syncytial Viruses	-
Ramucirumab	Phase 2	Gastroesophageal Junction	-
V114 Lot 1	Phase 2	Pneumococcal Infections	-
Vaniprevir 600 mg b.i.d.	Phase 2	Hepatitis C, Chronic	-
Belzutifan	Phase 2	Renal Cell Carcinoma	-
zoster vaccine live (Oka/Merck)	Phase 2	Shingles	-
favezelimab/pembrolizumab	Phase 2	Hodgkin Lymphoma	-
Gefapixant 45 mg	Phase 2	Chronic Cough	-
luspatercept	Phase 2	B-Thalassemia	-
Tulisokibart	Phase 2	Hidradenitis Suppurativa	-
Raludotatug Deruxtecan	Phase 2	Ovarian Cancer Recurrent	-
Comparator: Placebo (unspecified)	Phase 2	Paranoid Schizophrenia	-
Odanacatib	Phase 2	Osteoporosis Postmenopausal	-
adavosertib	Phase 2	Ovarian Cancer	-
IDX719	Phase 2	Hepatitis C, Chronic	-